Artificial intelligence (AI) software developer Icometrix has received U.S. Food and Drug Administration (FDA) 510(k) clearance for icobrain tbi, an AI software application for segmenting brain CT scans of patients with a traumatic brain injury (TBI).
Designed to help better characterize and manage TBI in the acute clinical setting, icobrain tbi uses deep learning to quantify clinically important metrics such as hyperdense volumes, cisternal compression, and midline shift, according to Icometrix. It's now part of the firm's icobrain image quantification software.
